MMRGlobal, Inc. (fka MMRF)

[george63080]

so....i called it right when i said he would try to make it more about pharma! here comes the new pump n dump!

Following up on rumors pertaining to post reverse merger news the MMRGlobal confirms that it has its eye on a transaction with a former Forward Ventures portfolio company formerly known as Tangent Pharmaceuticals in an effort to acquire the drug Fadratinab. Fadratinab was placed on hold by Sanofi after paying Forward Ventures 125 million dollars. The Company is also excited about Celgene's flagship myeloma drug Revlimid which has just been approved in the EU and US for newly-diagnosed patients expanding the target population for the drug. Revlimid also continues to be tested for treatments of lymphoma using MMR Biotech assets in conjunction with five phase III trials for indications such as follicular and diffuse large B-cell lymphomas.

ShareMessage